These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18254175)

  • 1. I read that the acid-suppressing drugs that I take to stop acid reflux increase risk of osteoporosis and hip fracture. Can I do anything to help prevent osteoporosis?
    Mayo Clin Health Lett; 2007 Dec; 25(12):8. PubMed ID: 18254175
    [No Abstract]   [Full Text] [Related]  

  • 2. PPI therapy: when to worry about fracture risk.
    Heidelbaugh JJ
    J Fam Pract; 2011 May; 60(5):255-60. PubMed ID: 21544271
    [No Abstract]   [Full Text] [Related]  

  • 3. Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.
    Fournier MR; Targownik LE; Leslie WD
    Maturitas; 2009 Sep; 64(1):9-13. PubMed ID: 19674854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm.
    Moayyedi P; Cranney A
    Am J Gastroenterol; 2008 Oct; 103(10):2428-31. PubMed ID: 18855852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological plausibility between proton pump inhibitory therapy and hip fracture: hyperhomocysteinemia can be the link.
    Roblin X; Phelip JM
    Am J Gastroenterol; 2009 Apr; 104(4):1052. PubMed ID: 19240711
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of proton pump-inhibiting drugs on mineral metabolism.
    Insogna KL
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S2-4. PubMed ID: 19262542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone up on proton pump inhibitors and fracture risk.
    Gendreau-Webb R
    Nursing; 2007 Oct; 37(10):60-1. PubMed ID: 17906557
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention and treatment of senile osteoporosis and hip fractures.
    Duque G; Demontiero O; Troen BR
    Minerva Med; 2009 Feb; 100(1):79-94. PubMed ID: 19277006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPIs and fracture risk.
    Med Lett Drugs Ther; 2013 Feb; 55(1410):15-6. PubMed ID: 23459458
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term therapy of acid-dependent diseases with proton pump inhibitors and risk of colorectal cancer (literature review)].
    Bordin DS; Masharova AA; Lazebnik LB
    Eksp Klin Gastroenterol; 2008; (4):36-8. PubMed ID: 19145902
    [No Abstract]   [Full Text] [Related]  

  • 11. Common ulcer drug increases risk of osteoporosis.
    Johns Hopkins Med Lett Health After 50; 2009 Jan; 20(11):7. PubMed ID: 19408411
    [No Abstract]   [Full Text] [Related]  

  • 12. Proton Pump Inhibitors and Bone Health: What the Orthopaedic Surgeon Needs to Know.
    Wagner SC
    JBJS Rev; 2018 Dec; 6(12):e6. PubMed ID: 30562209
    [No Abstract]   [Full Text] [Related]  

  • 13. Proton pump inhibitor use and enteric infections.
    Dial MS
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump-inhibiting drugs, calcium homeostasis, and bone health.
    Wright MJ; Proctor DD; Insogna KL; Kerstetter JE
    Nutr Rev; 2008 Feb; 66(2):103-8. PubMed ID: 18254877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux disease.
    Fernández-Fernández FJ
    N Engl J Med; 2009 Feb; 360(7):729; author reply 729-30. PubMed ID: 19222130
    [No Abstract]   [Full Text] [Related]  

  • 16. Stop the PPI express: they don't keep babies quiet!
    Putnam PE
    J Pediatr; 2009 Apr; 154(4):475-6. PubMed ID: 19324214
    [No Abstract]   [Full Text] [Related]  

  • 17. Unexpected consequences of proton pump inhibitor use.
    Altman KW; Radosevich JA
    Otolaryngol Head Neck Surg; 2009 Nov; 141(5):564-6. PubMed ID: 19861191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroesophageal reflux disease.
    Aguirre C; Ruiz-Irastorza G; Egurbide MV
    N Engl J Med; 2009 Feb; 360(7):729; author reply 729-30. PubMed ID: 19213690
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical implications of chronic therapy for GERD. Preface.
    Fass R
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S1. PubMed ID: 19262539
    [No Abstract]   [Full Text] [Related]  

  • 20. Inverse association between duration of use of acid-suppressive medications and fracture risk.
    de Vries F
    Arch Intern Med; 2011 Jun; 171(11):1044; author reply 1044. PubMed ID: 21670381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.